Search

Author/Creator Baker, Sharyn D.

1. A phase 1 study of the CXCR4 antagonist plerixafor in combination with high‐dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10‐03). Issue 8 (14th April 2017)

Authors:
Cooper, Todd M.; Sison, Edward Allan Racela; Baker, Sharyn D.; Li, Lie; Ahmed, Amina; Trippett, Tanya; Gore, Lia; Macy, Margaret E.; Narendran, Aru; August, Keith; Absalon, Michael J.; Boklan, Jessica; Pollard, Jessica; Magoon, Daniel; Brown, Patrick A.
Journal:
Pediatric blood & cancer
Issue:
Volume 64:Issue 8(2017)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Clinical significance of in vivo cytarabine-induced gene expression signature in AML. Issue 4 (2nd April 2016)

Authors:
Lamba, Jatinder K.; Pounds, Stanley; Cao, Xueyuan; Crews, Kristine R.; Cogle, Christopher R.; Bhise, Neha; Raimondi, Susana C.; Downing, James R.; Baker, Sharyn D.; Ribeiro, Raul C.; Rubnitz, Jeffrey E.
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 4(2016:Apr.)
Page Start:
909
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group. Issue 3 (September 2015)

Authors:
Brouwer, KLR; Aleksunes, LM; Brandys, B; Giacoia, GP; Knipp, G; Lukacova, V; Meibohm, B; Nigam, SK; Rieder, M; de Wildt, SN; on behalf of the Pediatric Transporter Working Group; Abdel‐Rahman, Susan; Aleksunse, Lauren M.; Baker, Sharyn D.; Bolger, Michael B.; Brandys, Barbara; Brouwer, Kim L. R.;...
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 98:Issue 3(2015:Sep.)
Page Start:
266
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Interaction Between Sex and Organic Anion‐Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib‐N‐Oxide and Regorafenib‐Glucuronide in Mice. Issue 4 (6th April 2019)

Authors:
Fu, Qiang; Chen, Mingqing; Anderson, Jason T.; Sun, Xinxin; Hu, Shuiying; Sparreboom, Alex; Baker, Sharyn D.
Journal:
Clinical and translational science
Issue:
Volume 12:Issue 4(2019)
Page Start:
400
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Palmar‐plantar erythrodysesthesia syndrome following treatment with high‐dose methotrexate or high‐dose cytarabine. Issue 18 (11th May 2017)

Authors:
Karol, Seth E.; Yang, Wenjian; Smith, Colton; Cheng, Cheng; Stewart, Clinton F.; Baker, Sharyn D.; Sandlund, John T.; Rubnitz, Jeffrey E.; Bishop, Michael W.; Pappo, Alberto S.; Jeha, Sima; Pui, Ching‐Hon; Relling, Mary V.
Journal:
Cancer
Issue:
Volume 123:Issue 18(2017)
Page Start:
3602
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1. Issue 1 (3rd September 2019)

Authors:
Chen, Mingqing; Neul, Claudia; Schaeffeler, Elke; Frisch, Franziska; Winter, Stefan; Schwab, Matthias; Koepsell, Hermann; Hu, Shuiying; Laufer, Stefan; Baker, Sharyn D.; Sparreboom, Alex; Nies, Anne T.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 107:Issue 1(2020)
Page Start:
227
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗